Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -2018/19 group results

May 14 (Reuters)- 
          Reprocell Incorporated 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT   
              Mar 31, 2019    Mar 31, 2018    Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           1.09           926 mln          1.43                  
               (+17.5 pct)     (-26.4 pct)    (+31.8 pct)               
  Operating   loss 781 mln      loss 1.03     loss 756 mln              
  Recurring   loss 627 mln    loss 935 mln    loss 687 mln              
  Net
  Net         loss 601 mln      loss 2.17     loss 687 mln              
  EPS         loss 8.79 yen  loss 34.28 yen  loss 9.66 yen              
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
  
  NOTE - Reprocell Incorporated.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news